Top Medical News Today

First  Biologic for Multi-Drug Resistant HIV Seems to Work
An experimental biologic for treating drug-resistant HIV showed dramatic results in phase 3 trials, researchers report. It's called ibalizumab.
Concerns that high-risk men on pre-exposure prophylaxis (PrEP) for HIV would stop using condoms and start getting other sexually transmitted infections have been somewhat validated in a Boston clinic.
Transmitted HIV drug resistance is a growing problem. Researchers found 20% of treat-naive HIV patients in a rural Southern US community had such transmitted drug resistant strains of the virus.
Not only is Brazilian AIDS and infectious disease specialist Mauro Schecter, MD, PhD, an expert in Zika, he was also a patient. In the opening session of IDWeek 2016, he described what that was like.
Noninvasive technology can accurately measure liver stiffnesss and track progress in liver disease cure.
Researchers calculate that more than 300,000 people in the US are now affected by the parasitic illness Chagas Disease, once limited to Latin and South America.
Antibiotics known to disrupt the microbiome appear to send more patients back to the hospital, CDC researchers found.
Hookworms aren't the common affliction that they once were, at least in the developed world, but asthma prevalence is growing. A new study winks at a correlation, suggesting that a protein in the pesky parasites may treat asthma.
A review of studies concludes that switching psoriatic arthritis patients who have stopped responding to one tumor necrosis factor inhibitor (TNFi) to another will likely reduce their symptoms, but the effectiveness of each new medication will likely be less than each former medication.

Most Popular


$vacMongoViewPlus$ $vAR$